Edward Robinson
Pulmonary Disease · Macon, GANPI 1306279955
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (41.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Intuitive Surgical at 41.4% of the total. 2025 is the largest year on record at $4,339, more than ten times the $27 reported in 2019.
Across 118 payments — averaging $55.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Olympus Corporation Of The Americas$1K
- Boehringer Ingelheim$420
- AstraZeneca$333
- Jazz Pharmaceuticals Inc.$299
- GSK$232
- plus $1K from 23 others
What the payments were for
- Travel & lodging$1,25519%
- Food & beverage$2,58740%
- Education$2,69841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 4 | $2,710 |
| Olympus Corporation Of The Americas | 7 | $1,091 |
| Boehringer Ingelheim | 19 | $420 |
| AstraZeneca(2 entities) | 19 | $333 |
| Jazz Pharmaceuticals Inc. | 4 | $299 |
| GSK | 8 | $232 |
| Insmed, Inc. | 10 | $153 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Heron Therapeutics, Inc. | 1 | $124 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $120 |
| Actelion Pharmaceuticals US, Inc. | 4 | $119 |
| Planmeca USA, Inc. | 1 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $101 |
| Axsome Therapeutics, Inc. | 5 | $98 |
| Merck | 6 | $89 |
| Inspire Medical Systems, Inc. | 1 | $73 |
| Olympus America Inc. | 2 | $69 |
| Grifols USA, LLC | 2 | $40 |
| Harmony Biosciences LLC | 1 | $34 |
| Blueprint Medicines Corporation | 1 | $32 |
| AbbVie | 2 | $27 |
| Genentech USA, Inc. | 2 | $26 |
| Idorsia Pharmaceuticals US Inc | 1 | $26 |
| Bayer | 1 | $16 |
| ZOLL Respicardia, Inc. | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
| Gilead | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,687
- Spiration Valve System$972
- XYWAV$149
- NUZYRA$125
- AREXVY$125
- Zynrelef$124
- PLANMECA PROMAX$109
How this compares
$6,540 in reported general payments places this provider in the 60th percentile of 365 pulmonary disease providers in Georgia.
Other pulmonary disease in Macon
- Gerald TarirahMacon$29K
- Charles CallenderMacon$20K
- John KingMacon$19K
- Lawrence McDermottSavannah$963K
- Vivek SambharaGainesville$417K
- Chad MillerAustell$382K
- Nehal BhattAthens$371K
- Maria MascoloRincon$358K
- Colin SwensonAtlanta$255K
- David MillerDecatur$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.